Literature DB >> 30183071

NLRP2 negatively regulates antiviral immunity by interacting with TBK1.

Yanqing Yang1,2, Xueting Lang2, Song Sun2, Chun Gao3, Jianguo Hu1, Shuqin Ding1, Jing Li1, Yuyun Li4, Fengchao Wang1, Tao Gong4,2.   

Abstract

Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are intracellular pattern recognition receptors (PRRs) that regulate a variety of inflammatory and host defense responses. Unlike the well-established NLRs, the roles of NLRP2 are controversial and poorly defined. Here, we report that NLRP2 acts as a negative regulator of TANK-binding kinase 1 (TBK1)-mediated type I interferon (IFN) signaling. Mechanistically, NLRP2 interacted directly with TBK1, and this binding disrupted the interaction of TBK1 and interferon regulatory factor 3 (IRF3), which interfered with TBK1-induced IRF3 phosphorylation. IFNs induce a series of proteins that have well-known antiviral or immune-regulatory functions, and tight control of the IFN signaling cascade is critical for limiting tissue damage and preventing autoimmunity. Our studies indicate that the NLRP2-TBK1 axis may serve as an additional signaling cascade to maintain immune homeostasis in response to viral infection.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antiviral innate immunity; NLRP2; TBK1; Type I interferons

Mesh:

Substances:

Year:  2018        PMID: 30183071     DOI: 10.1002/eji.201847589

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

2.  NLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells.

Authors:  Marianna N Rossi; Antonia Pascarella; Valerio Licursi; Ivan Caiello; Anna Taranta; Laura R Rega; Elena Levtchenko; Francesco Emma; Fabrizio De Benedetti; Giusi Prencipe
Journal:  Front Cell Dev Biol       Date:  2019-10-24

Review 3.  Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation.

Authors:  Ioannis Kienes; Tanja Weidl; Nora Mirza; Mathias Chamaillard; Thomas A Kufer
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

Review 4.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.

Authors:  Kiramage Chathuranga; Asela Weerawardhana; Niranjan Dodantenna; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2021-11-16       Impact factor: 8.718

5.  Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.

Authors:  Chaini Konwar; Rebecca Asiimwe; Amy M Inkster; Sarah M Merrill; Gian L Negri; Maria J Aristizabal; Christopher F Rider; Julie L MacIsaac; Christopher Carlsten; Michael S Kobor
Journal:  Epigenetics Chromatin       Date:  2021-12-11       Impact factor: 4.954

Review 6.  Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets.

Authors:  Sambit K Nanda; Stefan Vollmer; Ana B Perez-Oliva
Journal:  Front Cell Dev Biol       Date:  2022-06-21

7.  Oxysterols Modify NLRP2 in Epithelial Cells, Identifying a Mediator of Ozone-induced Inflammation.

Authors:  Alexia Perryman; Adam M Speen; Hye-Young H Kim; Jessica R Hoffman; Phillip W Clapp; William Rivera Martin; John N Snouwaert; Beverly H Koller; Ned A Porter; Ilona Jaspers
Journal:  Am J Respir Cell Mol Biol       Date:  2021-11       Impact factor: 6.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.